Form 4: Bioxytran Director Dale H. Conaway Reports Acquisition and Disposal of Preferred Stock

Director Dale H. Conaway reports acquiring 20,619 shares of preferred stock at $0.46 each and disposing of 232,637 shares.

Summary

• On October 25, 2024, Dale H. Conaway, a director of Bioxytran, Inc. (BIXT), reported a transaction involving the company's preferred stock.
• Conaway acquired 20,619 shares of preferred stock at a price of $0.46 per share.
• Conaway also disposed of 232,637 shares of preferred stock.
• Following these transactions, Conaway directly owns 232,637 shares of preferred stock.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director. The acquisition and disposal could have various motivations and don't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, and 10% owners) buy or sell their company's stock. They provide transparency into insider transactions and can be used by investors to gauge sentiment.

Stakeholder Impact

• The transactions may influence investor perception of the company's stock.

Key Dates

Keywords

Form 4, Bioxytran, BIXT, Director, Dale H. Conaway, Preferred Stock, Acquisition, Disposal, Beneficial Ownership, SEC